http://www.cnr.it/ontology/cnr/individuo/unitaDiPersonaleEsterno/ID1239
Giuseppe Montalto
- Type
- Label
- Giuseppe Montalto (literal)
- Giuseppe Montalto (literal)
- Subject
- Partecipa a commessa
- Persona in rapporto
- Autore CNR di
- Micro-RNA signature of human hepatocellular carcinoma (HCC). (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-±, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Transcriptional regulation of micro-RNAs highly expressed in human HCCS (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer (Abstract in rivista) (Prodotto della ricerca)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Sex hormones and risk of liver tumors (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Non invasive tools for the diagnosis of liver cirrhosis (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Transcriptional regulation of signature miRNAs. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Transcriptional regulation of micro-RNAs highly expressed in human HCCS (Abstract in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1105)
- Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- GSK-3 as potential target for therapeutic irvention in cancer. (Articolo in rivista) (Prodotto della ricerca)
- Cyclooxygenase-2, Tumor Necrosis Factor-±, Vascular Endothelial Growth factor-A and IL-6 genes SNPS and Il-6 serum levels in liver cirrhosis and hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Management of liver failure: from transplantation to cell-based therapy. (Articolo in rivista) (Prodotto della ricerca)
- Suppressing prostate cancer by targeting NGAL (Abstract in rivista) (Prodotto della ricerca)
- Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study (Abstract in rivista) (Prodotto della ricerca)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Emerging Raf inhibitors. (Articolo in rivista) (Prodotto della ricerca)
- Targeting signaling pathways in prostate cancer (Abstract/Comunicazione in rivista) (Prodotto della ricerca)
- Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study . (Articolo in rivista) (Prodotto della ricerca)
- Sex hormones and risk of liver tumor. (Articolo in rivista) (Prodotto della ricerca)
- Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
- Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation (Articolo in rivista) (Prodotto della ricerca)
- Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Emerging MEK inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Micro-RNA signature of human hepatocellular carcinoma (HCC). (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Sex hormones and risk of liver tumors (Abstract/Poster in convegno) (Prodotto della ricerca)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. (Articolo in rivista) (Prodotto della ricerca)
- DHMEQ and Celecoxib synergistically exert anti-tumoral activities in human liver cancer cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Transcriptional regulation of signature miRNAs (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- IL-6 -174G®C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Frequent alteration of the Yin Yang/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- GRP78 POLYMORPHISM rs430397 IS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN A SOUTHERN ITALIAN POPULATION (Abstract in rivista) (Prodotto della ricerca)
- Cyclooxygenases in hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Gene expression profiling of human liver cancer cells following celecoxib treatment. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment. (Articolo in rivista) (Prodotto della ricerca)
- Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Coautore
- Nome
- Cognome
- Afferisce a
- Ha pubblicazioni con
- Http://www.cnr.it/ontology/persone.owl#argomentoDiRicercaSimile
Incoming links:
- Autore CNR
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Sex hormones and risk of liver tumors (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Transcriptional regulation of micro-RNAs highly expressed in human HCCS (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Micro-RNA signature of human hepatocellular carcinoma (HCC). (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation (Articolo in rivista) (Prodotto della ricerca)
- Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Emerging MEK inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. (Articolo in rivista) (Prodotto della ricerca)
- Cyclooxygenases in hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment. (Articolo in rivista) (Prodotto della ricerca)
- Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-±, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
- Sex hormones and risk of liver tumor. (Articolo in rivista) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study . (Articolo in rivista) (Prodotto della ricerca)
- Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Emerging Raf inhibitors. (Articolo in rivista) (Prodotto della ricerca)
- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Management of liver failure: from transplantation to cell-based therapy. (Articolo in rivista) (Prodotto della ricerca)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Transcriptional regulation of signature miRNAs (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- IL-6 -174G®C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Frequent alteration of the Yin Yang/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- DHMEQ and Celecoxib synergistically exert anti-tumoral activities in human liver cancer cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Transcriptional regulation of micro-RNAs highly expressed in human HCCS (Abstract in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1105)
- Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Transcriptional regulation of signature miRNAs. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Cyclooxygenase-2, Tumor Necrosis Factor-±, Vascular Endothelial Growth factor-A and IL-6 genes SNPS and Il-6 serum levels in liver cirrhosis and hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Sex hormones and risk of liver tumors (Abstract/Poster in convegno) (Prodotto della ricerca)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Micro-RNA signature of human hepatocellular carcinoma (HCC). (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Gene expression profiling of human liver cancer cells following celecoxib treatment. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- GSK-3 as potential target for therapeutic irvention in cancer. (Articolo in rivista) (Prodotto della ricerca)
- Non invasive tools for the diagnosis of liver cirrhosis (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer (Abstract in rivista) (Prodotto della ricerca)
- Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study (Abstract in rivista) (Prodotto della ricerca)
- Suppressing prostate cancer by targeting NGAL (Abstract in rivista) (Prodotto della ricerca)
- Targeting signaling pathways in prostate cancer (Abstract/Comunicazione in rivista) (Prodotto della ricerca)
- GRP78 POLYMORPHISM rs430397 IS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN A SOUTHERN ITALIAN POPULATION (Abstract in rivista) (Prodotto della ricerca)
- Http://www.cnr.it/ontology/persone.owl#argomentoDiRicercaSimile
- Coautore
- Ha pubblicazioni con
- Ha afferente
- Partecipazione di
- Rapporto con persona
- Http://www.w3.org/2004/02/skos/core#isSubjectOf